|
TUV BioTech GmbH
TÜV BioTech is a joint venture of the TÜV Rheinland Group and Axiogenesis AG. TÜV Rheinland Group is an international certified body and technical service provider. More than 10,000 people are employed in 60 countries around the globe, generating revenues of approx. 800 million Euros. Our mission is sustainable development of safety and quality. TÜV BioTech shares its expertise on the new European chemicals directive REACH. According to this new legislation of the European Parliament, each company which exports substances into the European market has to register its components and its intended use. Therefore, TÜV BioTech developed the IT-based system SimREACH, which is able to translate the registration process under REACH requirements, to forecast the costs and to find cost reduction strategies.
Contact information:
| Country: | Germany
|
| City: | Cologne |
| Postal address: | Nattermannallee 1, Laborgebäude S20 |
| Postal code: | 50829 |
| Telephone number: | 49 (0)221 690589-14 |
| Fax: | 49 (0)221 690589-13 |
| Web page: | http://www.tuv.com/biotech |
| Email: | Contact us now |
|